Our client, a startup partnered with an international pharmaceutical company aimed to launch their novel solution in the Parkinson’s Disease market in the EU and US. The product was a unique formulation, overcoming low gastrointestinal absorption of oral levodopa/carbidopa. LSC was brought in to map the landscape and embarked on a detailed competitive landscape analysis, combining both primary and secondary research. Additionally, a set of targeted intelligence questions was explored in primary research and at conferences, to identify unique selling points and market perceptions of the product. This strategic insight enables the client to effectively position their product and set them apart in the competitive Parkinson’s Disease market in both US and EU.